Capitol Clarity / Firms / Soleno Therapeutics, Inc.

Soleno Therapeutics, Inc.

Soleno Therapeutics, Inc. lobbies on its own behalf. For Q3 2026 it reported $70K across 1 client report and lists 2 lobbyists across its filings. Issues include Economics/Economic Development, Financial Institutions/Investments/Securities, Health Issues and Insurance.

Clients, Q3 2026

ClientReportedIssues
SOLENO THERAPEUTICS, INC.$70KEconomics/Economic Development, Financial Institutions/Investments/Securities, Health Issues

By year

YearReportedClients
2026$220K1

Lobbyists listed

Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.